These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 50555

  • 1. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul 18; 17(15):62-3. PubMed ID: 50555
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM, Close HP.
    Cancer Chemother Rep; 1970 Jun 18; 54(3):195-8. PubMed ID: 4334088
    [No Abstract] [Full Text] [Related]

  • 3. How to use cancer chemotherapy.
    Dollinger MR.
    Am Fam Physician; 1971 Jun 18; 3(6):73-84. PubMed ID: 4325596
    [No Abstract] [Full Text] [Related]

  • 4. [Study of the action of antitumor compounds on primary explants from human tumors].
    Navashin SM, Fomina IP, Osokina LI, Zharikov AA.
    Antibiotiki; 1967 Sep 18; 12(9):803-7. PubMed ID: 4171894
    [No Abstract] [Full Text] [Related]

  • 5. Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE, Bross ID, Ausman R, Nadler S, Jones R, Slack N, Rimm AA.
    Cancer Chemother Rep; 1968 Oct 18; 52(6):675-84. PubMed ID: 5753587
    [No Abstract] [Full Text] [Related]

  • 6. The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.
    Sullivan RD, Miller E.
    Cancer Res; 1965 Aug 18; 25(7):1025-33. PubMed ID: 4284747
    [No Abstract] [Full Text] [Related]

  • 7. Combination phase 1-II study of imidazole carboxamide (NCS45388).
    Wagner DE, Ramirez G, Weiss AJ, Hill G.
    Oncology; 1972 Aug 18; 26(2):310-6. PubMed ID: 5049924
    [No Abstract] [Full Text] [Related]

  • 8. Phase I study of weekly administration of anhydroara-5-fluorocytidine (NSC-166641).
    Alberto P, Medenica R, Germano G, Bollag W.
    Cancer Treat Rep; 1976 Mar 18; 60(3):281-3. PubMed ID: 1260783
    [No Abstract] [Full Text] [Related]

  • 9. Intermittent dose schedule of mitomycin C (NSC-26980) in solid tumors.
    Kenis Y, Stryckmans P.
    Cancer Chemother Rep; 1972 Apr 18; 56(2):151. PubMed ID: 5043222
    [No Abstract] [Full Text] [Related]

  • 10. Combination cancer chemotherapy by regional intra-arterial or intra-aortic infusion of 5-fluorouracil and mitomycin-C with or without irradiation.
    Miura T, Ishida M, Hatano S.
    Jpn J Surg; 1971 Jun 18; 1(2):133-45. PubMed ID: 5173067
    [No Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
    Van Dyk JJ, Clarkson BD, Duschinsky R, Keller O, La Sala E, Krakoff IH.
    Cancer Res; 1967 Nov 18; 27(11):2129-36. PubMed ID: 4294532
    [No Abstract] [Full Text] [Related]

  • 12. Phase 2 study with Baker's Antifol in solid tumors.
    Rodriguez V, Richman SP, Benjamin RS, Burgess MA, Murphy WK, Valdivieso M, Banner RL, Gutterman JU, Bodey GP, Freireich EJ.
    Cancer Res; 1977 Apr 18; 37(4):980-3. PubMed ID: 139205
    [Abstract] [Full Text] [Related]

  • 13. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
    Gary-Bobo J.
    J Radiol Electrol Med Nucl; 1971 Dec 18; 52(12):858-62. PubMed ID: 4113798
    [No Abstract] [Full Text] [Related]

  • 14. [Combined application of drugs in cancer chemotherapy with special reference to the combination of mitomycin C, 5-fluorouracil, and cytosine arabinoside].
    Nakao I, Furue H, Furukawa K, Kanko T, Harashima S.
    Gan No Rinsho; 1972 Feb 18; 18(2):138-43. PubMed ID: 5063156
    [No Abstract] [Full Text] [Related]

  • 15. Cancer palliation by solid tumor chemotherapy. 3.
    Watne AL.
    W V Med J; 1969 Aug 18; 65(8):235-40. PubMed ID: 4186263
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA, Ratkin G, Klahr C.
    Cancer Treat Rep; 1978 Apr 18; 62(4):549-50. PubMed ID: 350389
    [No Abstract] [Full Text] [Related]

  • 17. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
    Burke PJ, Owens AH, Colsky J, Shnider BI, Edmonson JH, Schilling A, Brodovsky HS, Wallace HJ, Hall TC.
    Cancer Res; 1970 May 18; 30(5):1512-5. PubMed ID: 5426952
    [No Abstract] [Full Text] [Related]

  • 18. The current management of malignancy -- VI other solid tumors.
    Panettiere FJ.
    Alaska Med; 1977 Mar 18; 19(2):19-25. PubMed ID: 326087
    [No Abstract] [Full Text] [Related]

  • 19. Mitomycin C in advanced cervical cancer.
    Tonusin A, Lorvidhaya V, Punpae P, Changwiwit W, Charoeniam V, Ployleumsang D, Issariyodom P.
    J Med Assoc Thai; 1987 May 18; 70(5):275-9. PubMed ID: 2821141
    [No Abstract] [Full Text] [Related]

  • 20. Chemotherapy in prevention of the recurrence of resectable cancer.
    Bonadonna G, Tancini G, Rossi A, Gasparini M.
    Annu Rev Med; 1978 May 18; 29():149-75. PubMed ID: 206184
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.